Europe Adopted New Vaccine to Protect People from Dengue
The European Medicine Agency’s human medicine committee (CHMP) has adopted a positive opinion for Dengue Tetravalent Vaccine, which is used to prevent disease caused by dengue virus serotypes 1, 2, 3, and 4 in people from 4 years of age. Dengue is a mosquito-borne disease caused by four types of the dengue virus that leads […]
Continue Reading